公司資料
Catalyst Biosciences 股價、新聞與催化劑
- 股票代碼:
- CBIO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
13.14 USD (-0.23%)
收盤價
最後更新: 2026年10月22日
469M USD
市值
股價為何變動
截至 2026年10月22日，CBIO 股價變化不大，收於 $13.14。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Catalyst Biosciences was a biotechnology company focused on engineered proteins for hemostasis, complement, and related inflammatory biology before becoming a historical ticker. Its story was built around protein-engineering approaches to difficult disease pathways.
所在地與產業分類
Catalyst Biosciences was headquartered in the United States and listed on NASDAQ. It sat in specialty biotech with a protein-engineering focus.
商業模式特徵
The company depended on translational data, strategic direction, and financing while working through a narrow pipeline. Investors historically watched whether the platform could create durable value across multiple programs.
生技產業定位
Catalyst Biosciences belongs to the historical engineered-protein biotech bucket. Its stock was highly sensitive to strategic changes and the viability of its platform thesis.
未來催化劑
- Catalyst Biosciences is largely a legacy / closeout story, with catalysts limited to any remaining strategic update. There is no active standalone growth story left.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。